ArticleDrug safety - case reports2016

Dosing Recommendations of Aripiprazole Depot with Strong Cytochrome P450 3A4 Inhibitors: A Relapse Risk.

Martina Hahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.